Cardiovascular disease: risk assessment and reduction, including lipid modification
In development [GID-NG10178] Expected publication date: 19 April 2023
In development [GID-NG10178] Expected publication date: 19 April 2023
In development [GID-NG10159] Expected publication date: TBC
In development [GID-NG10120] Expected publication date: 17 June 2021
In development [GID-NG10141] Expected publication date: 17 November 2021
In development [GID-NG10153] Expected publication date: 20 July 2022
In development [GID-NG10176] Expected publication date: 23 March 2023
In development [GID-NG10109] Expected publication date: 09 June 2021
In development [GID-NG10127] Expected publication date: 10 August 2022
In development [GID-NG10111] Expected publication date: 12 April 2021
In development [GID-NG10174] Expected publication date: 22 March 2023
In development [GID-NG10123] Expected publication date: 09 December 2021
In development [GID-NG10182] Expected publication date: 22 June 2022
In development [GID-NG10119] Expected publication date: 25 August 2021
In development [GID-NG10150] Expected publication date: 22 June 2022
In development [GID-NG10165] Expected publication date: 23 January 2023
In development [GID-NG10091] Expected publication date: 21 April 2021
In development [GID-CGWAVE0725] Expected publication date: 12 May 2022
In development [GID-NG10148] Expected publication date: 18 May 2022
In development [GID-NG10151] Expected publication date: 13 June 2022
In development [GID-NG10149] Expected publication date: 08 June 2022
In development [GID-NG10098] Expected publication date: TBC
In development [GID-NG10122] Expected publication date: 08 September 2021
In development [GID-NG10105] Expected publication date: 23 November 2021
In development [GID-NG10069] Expected publication date: TBC
In development [GID-NG10100] Expected publication date: 12 March 2021
In development [GID-NG10185] Expected publication date: TBC
In development [GID-NG10118] Expected publication date: 30 June 2021
In development [GID-NG10082] Expected publication date: 14 October 2021
In development [GID-NG10081] Expected publication date: 31 March 2021
In development [GID-NG10155] Expected publication date: 25 May 2022
In development [GID-NG10097] Expected publication date: 21 July 2021
In development [GID-NG10177] Expected publication date: 19 April 2023
In development [GID-DG10036] Expected publication date: TBC
In development [GID-DG10040] Expected publication date: 17 November 2021
In development [GID-DG10039] Expected publication date: 17 November 2021
In development [GID-DG10042] Expected publication date: 13 April 2022
In development [GID-DG10041] Expected publication date: 23 February 2022
In development [GID-DG10038] Expected publication date: 06 January 2021
In development [GID-DG10034] Expected publication date: 17 February 2021
In development [GID-DG10029] Expected publication date: 13 January 2021
Evidence-based recommendations on the EOS 2D/3D imaging system for producing 2D and 3D images of the skeleton
Evidence-based recommendations on SonoVue (sulphur hexafluoride microbubbles) for contrast-enhanced ultrasound imaging of the liver
Evidence-based recommendations on SeHCAT (tauroselcholic [75selenium] acid) for diagnosing bile acid malabsorption in people with IBS-D or Crohn’s disease
Evidence-based recommendations on tumour profiling tests to guide adjuvant chemotherapy decisions for people with early breast cancer. The tests are EndoPredict
Evidence-based recommendations on lead-I electrocardiogram (ECG) devices (imPulse, Kardia Mobile, MyDiagnostick and Zenicor-ECG) for detecting symptomatic
Evidence-based recommendations on enzyme-linked immunosorbent assay (ELISA) tests for therapeutic monitoring of tumour necrosis factor (TNF)-alpha inhibitors in
Evidence-based recommendations on rapid tests for group A streptococcal infections in people aged 5 and over with a sore throat
Evidence-based recommendations on tests to help assess risk of acute kidney injury for people being considered for critical care admission. The tests are the
Evidence-based recommendations on high-sensitivity troponin tests for the early rule out of NSTEMI (non-ST-segment elevation myocardial infarction)
Evidence-based recommendations on implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke